- Home
- TOVX vs JNVR Comparison
TOVX vs JNVR Comparison
Compare TOVX & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TOVX
- JNVR
- Stock Information
- Founded
- TOVX 2001
- JNVR 2018
- Country
- TOVX United States
- JNVR United States
- Employees
- TOVX 22
- JNVR N/A
- Industry
- TOVX Biotechnology: Pharmaceutical Preparations
- JNVR Finance: Consumer Services
- Sector
- TOVX Health Care
- JNVR Finance
- Exchange
- TOVX Nasdaq
- JNVR Nasdaq
- Market Cap
- TOVX 3.2M
- JNVR 7.3M
- IPO Year
- TOVX 2006
- JNVR 2023
- Fundamental
- Price
- TOVX $1.14
- JNVR $0.68
- Analyst Decision
- TOVX Strong Buy
- JNVR
- Analyst Count
- TOVX 1
- JNVR 0
- Target Price
- TOVX $6.00
- JNVR N/A
- AVG Volume (30 Days)
- TOVX 97.3K
- JNVR 200.0K
- Earning Date
- TOVX 11-12-2024
- JNVR 11-06-2024
- Dividend Yield
- TOVX N/A
- JNVR N/A
- EPS Growth
- TOVX N/A
- JNVR N/A
- EPS
- TOVX N/A
- JNVR N/A
- Revenue
- TOVX N/A
- JNVR $1,820,969.00
- Revenue This Year
- TOVX N/A
- JNVR N/A
- Revenue Next Year
- TOVX N/A
- JNVR N/A
- P/E Ratio
- TOVX N/A
- JNVR N/A
- Revenue Growth
- TOVX N/A
- JNVR N/A
- 52 Week Low
- TOVX $1.14
- JNVR $0.42
- 52 Week High
- TOVX $17.00
- JNVR $1.48
- Technical
- Relative Strength Index (RSI)
- TOVX 36.15
- JNVR 55.82
- Support Level
- TOVX $1.23
- JNVR $0.60
- Resistance Level
- TOVX $1.21
- JNVR $0.71
- Average True Range (ATR)
- TOVX 0.07
- JNVR 0.10
- MACD
- TOVX 0.01
- JNVR 0.00
- Stochastic Oscillator
- TOVX 0.00
- JNVR 48.36
About TOVX Theriva Biologics Inc.
Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a lead clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system.
About JNVR Janover Inc.
Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.